Development of a mHealth Intervention for Ambivalent Smokers

• Status: Completed
• Trial end date: 2021-09-27
• Target enrollment: 0
• Participant gender: All

Summary

The current pilot study will assess the feasibility and acceptability of a novel mHealth app designed for people who are ambivalent about quitting smoking. Results will be used to refine the intervention and plan for a future randomized effectiveness trial.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Kaiser Permanente
• Collaborator: National Cancer Institute (NCI)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• 18 years or older;

• Can speak/read English;

• Current smoker;

• Own and regularly use an eligible smartphone;

• No vision impairments;

• Willing to install and use the study program;

• Willing to use birth control if elect to use nicotine replacement during the study (females);

• Meet definition for ambivalence

• Not actively using treatment

Exclusion Criteria:

• Smoke less than 10 cigarettes per day

• Self-report a lifetime history of dementia, manic depression, bipolar disorder, or schizophrenia;

• Have medical contraindications for nicotine replacement therapy;

• Another household member is enrolled in the study

• Unable to verify contact information

• Fail to install app